Abstract
Purpose
Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Radiotherapy and OncologyReferences
- Estimating the population benefit of radiotherapy: using demand models to estimate achievable cancer outcomes.Clin Oncol (R Coll Radiol). 2015; 27: 99-106
- Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach.Clin Oncol (R Coll Radiol). 2007; 19: 481-489
- The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.Cancer. 2005; 104: 1129-1137
- Role of radiotherapy in cancer control in low-income and middle-income countries.Lancet Oncol. 2006; 7: 584-595
- The Malthus programme – a new tool for estimating radiotherapy demand at a local level.Clin Oncol (R Coll Radiol). 2012; 24: 1-3
- An evidence-based estimate of the appropriate rate of utilization of radiotherapy for cancer of the cervix.Int J Radiat Oncol Biol Phys. 2005; 63: 812-827
- Estimating the benefit and cost of radiotherapy for lung cancer.Int J Technol Assess Health Care. 2004; 20: 545-551
- An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer.Radiother Oncol. 2007; 84: 11-17
- Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I – malignancies of the cervix, ovary, vagina and vulva.Cancer. 2004; 101: 671-681
National Health and Medical Research Council, NHMRC levels of evidence and grades for recommendations for developers of guidelines. 2009: Australian Government.
Ng, W.L., Estimating the optimal chemotherapy utilisation rate as an evidence-based benchmark in cancers of the breast, upper gastrointestinal tract, gynaecological tract, head and neck, kidney, bladder, thyroid and unknown primary. 2010. Sydney, Australia: University of New South Wales (Ph. D Thesis).
- Classics in oncology. Survival in untreated and treated cancer.CA Cancer J Clin. 1984; 34: 282-294
- Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer care.Eur J Cancer. 2009; 45: 2150-2159
- Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma.Cancer. 2005; 103: 2216-2227
- A simple hybrid variance estimator for the Kaplan–Meier survival function.Stat Med. 2005; 24: 827-851
- Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.Stat Med. 1998; 17: 2815-2834
- Practical methods for incorporating summary time-to-event data into meta-analysis.Trials. 2007; 8: 16
Greater Metropolitan Clinical Taskforce, Best Clinical Practice Gynaecological Cancer Guidelines. 2009, North Sydney, NSW: NSW Department of Health.
National Cancer Institute, Cervical Cancer Treatment PDQ Health Professional Version Available at http://www.cancer.gov/cancertopics/pdq/adulttreatment. 2012.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology-v 2.2013-Cervical Cancer. Available at http://www.nccn.org. 2013.
Alberta Health Services, Cancer of the Uterine Cervix Clinical Practice Guideline GYNE-004 Available at: http://www.albertahealthservices.ca. 2012, Alberta.
Vergote, I., et al., Een nationale praktijkrichtlijn voor de aanpak van cervixkanker. Good Clinical Practice (GCP). 2011, Brussels: Federaal Kenniscentrum voor de Gezondheidszorg (KCE).
BC Cancer Agency, Uterine Cervix Management Invasive – Squamous Cell Carcinoma & Adenocarcinoma. Available at http://www.bccancer.bc.ca. 2006: BC Cancer Agency.
- Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2010; 21: v37-v40
Scottish Intercollegiate Guidelines Network, 99 Management of cervical cancer: A national clinical guideline. Available at http://www.sign.ac.uk. 2008.
Lukka, H., et al., Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation. Practice Guideline Report #4-5, in Program in Evidence-Based Care. 2004, Cancer Care Ontario.
eviQ, Radiation Oncology, Gynaecological, Cervix, Definitive, EBRT 2013: Cancer Institute; NSW.
Gaffney, D.K., et al., Advanced Cervical Cancer. ACR Appropriateness Criteria. 2012: American College of Radiology.
Sydney Gynaecological Oncology Group. Cervical Cancer. 2012 5 Jan 2012; Available from: http://www.sswahs.nsw.gov.au/SSWAHS/sgog/Vulva_Guide.html.
YCN Gynaecology Network Site Specific Group, Guidelines for the Management of Gynaecological Cancers. 2012: Yorkshire Cancer Network.
- Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure.Int J Radiat Oncol Biol Phys. 1995; 31: 31-36
- Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.Gynecol Oncol. 2005; 96: 721-728
- Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.J Clin Oncol. 2000; 18: 1606-1613
- A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.Int J Radiat Oncol Biol Phys. 2006; 65: 169-176
- Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.Tumori. 2005; 91: 295-301
- Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery.Int J Gynecol Cancer. 1993; 3: 193-198
- Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.Am J Obstet Gynecol. 2007; 197 (p. 503 e1–6)
National Cancer Institute, SEER∗Stat 6.6.2. 2010, Silver Spring, MD: The Surveillance Research Program of the Division of Cancer Control and Population Sciences, National Cancer Institute.
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC), Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev, 2010(1). p. CD008285.
- Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.Int J Radiat Oncol Biol Phys. 2003; 55: 1226-1232
- Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.Int J Cancer. 2000; 90: 206-223
- Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79–20.JAMA. 1995; 274: 387-393
- A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer.Int J Gynecol Cancer. 1992; 2: 244-251
- A randomized trial of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy alone in Stage IIIb carcinoma of the uterine cervix.J Gynecol Surg. 2010; 26: 105-113
- Close vaginal margins as a prognostic factor after radical hysterectomy.Gynecol Oncol. 1998; 68: 229-232
- Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer.Int J Radiat Oncol Biol Phys. 2006; 65: 1501-1507
Ferlay, J., et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Available from: http://globocan.iarc.fr, accessed on 27 September 2014. 2013, Lyon, France: International Agency for Research on Cancer.
Barton, M.B., et al., Review of optimal radiotherapy utilisation rates. http://tinyurl.com/pwkua34. 2012, Sydney: Ingham Institute, Collaboration for Cancer Outcomes Research and Evaluation.
- Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012.Radiother Oncol. 2014; 112: 140-144
- Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study.J Clin Oncol. 2007; 25: 2383-2388
